SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE

Bibliographic Details
Main Author: Stefan Lichtenthaler
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:IBRO Neuroscience Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2667242123022248
_version_ 1797636080582787072
author Stefan Lichtenthaler
author_facet Stefan Lichtenthaler
author_sort Stefan Lichtenthaler
collection DOAJ
first_indexed 2024-03-11T12:29:03Z
format Article
id doaj.art-d785d976069241a5a31bf15925dddd54
institution Directory Open Access Journal
issn 2667-2421
language English
last_indexed 2024-03-11T12:29:03Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series IBRO Neuroscience Reports
spelling doaj.art-d785d976069241a5a31bf15925dddd542023-11-06T04:28:59ZengElsevierIBRO Neuroscience Reports2667-24212023-10-0115S53SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASEStefan Lichtenthaler0German Center for Neurodegenerative Diseases (DZNE), Neuroproteomics, Munich, Germanyhttp://www.sciencedirect.com/science/article/pii/S2667242123022248
spellingShingle Stefan Lichtenthaler
SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE
IBRO Neuroscience Reports
title SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE
title_full SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE
title_fullStr SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE
title_full_unstemmed SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE
title_short SHEDDING OF TREM2 AND APP AS DRUG TARGETS IN ALZHEIMER’S DISEASE
title_sort shedding of trem2 and app as drug targets in alzheimer s disease
url http://www.sciencedirect.com/science/article/pii/S2667242123022248
work_keys_str_mv AT stefanlichtenthaler sheddingoftrem2andappasdrugtargetsinalzheimersdisease